Published 2004 | Version v1
Journal article

Conjugated docosahexaenoic acid suppresses KPL-1 human breast cancer cell growth in vitro and in vivo: potential mechanisms of action

  • 1. Department of Plastic and Reconstructive Surgery, Kansai Medical University, Moriguchi, Osaka (Japan)
  • 2. Department of Pathology II, Kansai Medical University, Moriguchi, Osaka (Japan)
  • 3. Division of Surgery, Kansai Medical University Kori Hospital, Neyagawa, Osaka (Japan)
  • 4. R&D Division, Bizen Chemical Co., Ltd, Okayama (Japan)
  • 5. Laboratory of Biodynamic Chemistry, Tohoku University Graduate School of Life Science and Agriculture, Sendai (Japan)

Description

The present study was conducted to examine the effect of conjugated docosahexaenoic acid (CDHA) on cell growth, cell cycle progression, mode of cell death, and expression of cell cycle regulatory and/or apoptosis-related proteins in KPL-1 human breast cancer cell line. This effect of CDHA was compared with that of docosahexaenoic acid (DHA). KPL-1 cell growth was assessed by colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay; cell cycle progression and mode of cell death were examined by flow cytometry; and levels of expression of p53, p21Cip1/Waf1, cyclin D1, Bax, and Bcl-2 proteins were examined by Western blotting analysis. In vivo tumor growth was examined by injecting KPL-1 cells subcutaneously into the area of the right thoracic mammary fat pad of female athymic mice fed a CDHA diet. CDHA inhibited KPL-1 cells more effectively than did DHA (50% inhibitory concentration for 72 hours: 97 μmol/l and 270 μmol/l, respectively). With both CDHA and DHA growth inhibition was due to apoptosis, as indicated by the appearance of a sub-G1 fraction. The apoptosis cascade involved downregulation of Bcl-2 protein; Bax expression was unchanged. Cell cycle progression was due to G0/G1 arrest, which involved increased expression of p53 and p21Cip1/Waf1, and decreased expression of cyclin D1. CDHA modulated cell cycle regulatory proteins and apoptosis-related proteins in a manner similar to that of parent DHA. In the athymic mouse system 1.0% dietary CDHA, but not 0.2%, significantly suppressed growth of KPL-1 tumor cells; CDHA tended to decrease regional lymph node metastasis in a dose dependent manner. CDHA inhibited growth of KPL-1 human breast cancer cells in vitro more effectively than did DHA. The mechanisms of action involved modulation of apoptosis cascade and cell cycle progression. Dietary CDHA at 1.0% suppressed KPL-1 cell growth in the athymic mouse system

Availability note (English)

Available from http://dx.doi.org/10.1186/bcr789; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC468623

Additional details

Publishing Information

Journal Title
Breast Cancer Research (Print)
Journal Volume
6
Journal Issue
4
Journal Page Range
p. 291-299
ISSN
1465-5411

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47028852
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
APOPTOSIS; CELL CYCLE; CONCENTRATION RATIO; GROWTH; IN VITRO; IN VIVO; LYMPH NODES; MAMMARY GLANDS; MICE; NEOPLASMS; POTENTIALS; PROTEINS; TUMOR CELLS
Descriptors DEC
ANIMAL CELLS; ANIMALS; BODY; DIMENSIONLESS NUMBERS; DISEASES; GLANDS; LYMPHATIC SYSTEM; MAMMALS; ORGANIC COMPOUNDS; ORGANS; RODENTS; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2004 Tsujita-Kyutoku et al.
Notes
PMCID: PMC468623; PUBLISHER-ID: bcr789; PMID: 15217495; OAI: oai:pubmedcentral.nih.gov:468623; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL